Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|May 3, 2021
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing CholangitisFrancesco Saettini, Grazia Fazio, Daniele Moratto, et al.
Journal of Clinical Immunology|September 28, 2023
Antibody Deficiency in Patients with Biallelic KARS1 MutationsFrancesco Saettini, Fabiola Guerra, Grazia Fazio, et al.
Hemasphere|June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic LeukemiaChiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Ebiomedicine|August 19, 2022
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
Scientific Reports|November 6, 2020
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesisMarta Isidro-Hernández, Andrea Mayado, Ana Casado-García, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
International Journal of Molecular Sciences|June 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack® Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL StudyIrene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, et al.
The Journal of Clinical Investigation|August 12, 2020
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicitiesChiara F Magnani, Giuseppe Gaipa, Federico Lussana, et al.
International Journal of Molecular Sciences|May 14, 2022
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or LymphomaAnne Schedel, Ulrike Anne Friedrich, Mina N F Morcos, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Pageof 7